Related Experiment Video
Updated: Aug 18, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
[Percutaneous coronary intervention]
1Debreceni Egyetem, Orvos- és Egészségtudományi Centrum, Altalános Orvostudományi Kar, Kardiológiai Intézet.
Insights
Percutaneous coronary intervention outcomes depend on patient, lesion, and procedure factors. Drug-eluting stents and extended antiplatelet therapy improve results by reducing restenosis and repeat procedures.
Area of Science:
- Cardiology
- Interventional Cardiology
- Biomedical Engineering
Context:
- Percutaneous coronary intervention (PCI) is a key treatment for coronary artery disease.
- Optimizing PCI outcomes requires understanding numerous influencing factors.
- Drug-eluting stents (DES) have significantly advanced PCI efficacy.
Purpose:
- To provide a comprehensive overview of percutaneous coronary intervention.
- To identify key predictive factors influencing PCI outcomes.
- To highlight advancements and best practices in PCI.
Summary:
- PCI outcomes are multifactorial, involving stent thrombogenicity, patient-specific issues, target lesion characteristics, and procedural details.
- Stent design, surface modifications, and pharmacotherapeutic agents impact platelet activation and clinical results.
- Drug-eluting stents demonstrate significant reductions in restenosis and repeat revascularization compared to bare-metal stents.
- Optimal stent sizing and deployment are crucial for procedural success.
- Use of glycoprotein IIb/IIIa inhibitors during complex procedures and extended post-procedural antiplatelet therapy (≥1 year) are recommended.
Impact:
- Improved patient outcomes and reduced need for repeat procedures through optimized PCI strategies.
- Enhanced understanding of factors influencing stent performance and thrombogenicity.
- Guidance on the appropriate use of drug-eluting stents and antiplatelet therapies for long-term efficacy.
Abstract:
The aim of this article was to provide an overview on percutaneous coronary intervention and to identify the predictive factors of the outcome. Numerous and diverse factors have been associated with interventional treatment that include intrinsic stent thrombogenicity and patient-, target lesion-, and procedure-related issues. Stent design, surface coating and the addition of adjunctive pharmacotherapeutic agents may influence the degree of platelet activation. The application of drug eluting stents represents a potential landmark event for percutaneous vascular treatment because marked reductions in restenosis and repeat revascularization rates have been observed with drug eluting stents in randomized trials. Every effort should be made to optimize stent size and deployment. Periprocedural glycoprotein IIb/IIIa inhibitors should be used for complex stent procedures and post-procedural antiplatelet therapy should be extended for at least 1 year.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Peripheral Artery Disease III: Interprofessional Care
Angina IV: Management
Cardiac Catheterization III: Left Heart Catheterization
